Siloxane monitoring
Protecting engines, turbines, and upgrading systems Siloxanes remain a persistent challenge in biogas, landfill gas, and biomethane production. When combusted, these silicon-containing compounds form abrasive silica deposits that damage engines, turbines, and catalytic systems — increasing maintenance costs, downtime, and operational risk. Detecting siloxane breakthrough early is critical. Traditional monitoring approaches often rely on laboratory […]
GC-IMS – Seeing molecules differently
Why GC-IMS is becoming the platform for rapid VOC intelligence Volatile organic compounds carry information — about flavour, contamination, process drift, safety, and biological state.The challenge has always been extracting that information quickly, robustly, and outside specialist laboratories. GC-IMS changes that equation. By coupling fast gas chromatography with ion mobility spectrometry, GC-IMS delivers: GC-IMS routinely […]
Food & Flavour
From sensory judgement to objective molecular fingerprints Sensory panels remain a gold standard — but they are costly, limited in scope, difficult to redeploy across products, and constrained in operational hours. Scaling them across multiple formulations and production sites is challenging. GC-IMS provides an objective, reproducible alternative:a three-dimensional VOC fingerprint of any food or beverage […]
Industrial & process monitoring
Real-time VOC monitoring without GC-MS complexity Traditional VOC monitoring typically means: GC-IMS offers a different route: Applications already proven: We offer demos, collaborative GC-IMS access, short-term rental and pilot installations, joint research and grant partnerships, data and method support, instrument sales, and full technical training. For companies needing VOC intelligence at the point of process, […]
Academic & Research
A new analytical workhorse for VOC-driven research GC-IMS is rapidly becoming a powerful research platform across:• Food science• Microbial metabolomics• Environmental chemistry• Biomedical VOC diagnostics Peer-reviewed studies show GC-IMS:• Detects microbial VOCs directly from blood-culture headspace• Identifies characteristic VOC marker patterns from microorganisms already present or actively growing• Provides rapid, high-throughput metabolomic fingerprints With two-dimensional […]
Recent Grant Success: Strengthening Our Growth and Capability
Imspex Diagnostics is pleased to confirm that we have secured further support through the Welsh Government SMART Digital and Productivity Accelerator programme, recognising the company’s continued progress and growth potential. This award reflects confidence in Imspex as an innovation-led business delivering advanced analytical technology across healthcare, industry and security sectors. The programme will support an […]
Business Development (Analytical Chemistry / Biology / Instrumentation)
Imspex Diagnostics is expanding its commercial team and we’re looking for a standout Business Development professional with a proven track record in analytical instrumentation. You’ll already be confident selling platforms such as HPLC, LC-MS, GC, GC-MS, SPE, Flash, ICP, and Purification systems, and you know how to engage technically minded customers across clinical and industry […]
Imspex at the IABR Summit 2025
Representing Imspex Diagnostics at the forefront of global breath research Our Senior Research Scientist & Technical Support, Hannah Deane-Cutler, recently attended the International Association of Breath Research (IABR) Summit 2025 in Innsbruck, Austria. The event gathered researchers, clinicians, and industry leaders to share the latest developments in breath analysis across oncology, infectious diseases, gastrointestinal disorders, […]
Imspex to Present at BioSeed 2025
We’re pleased to share that Imspex Diagnostics will be represented at BioSeed 2025, taking place on 9 June in London. Hosted by OBN, BioSeed is a high-impact investment event that brings together early-stage R&D companies and a room full of active life sciences investors. John McKinley, our CEO & Director, will be presenting at the […]
Imspex at Arab Health 2025
Imspex Diagnostics is proud to announce our participation at Arab Health 2025, one of the world’s largest healthcare exhibitions, taking place from 27th to 30th January 2025 in Dubai. You can find us on the Welsh Government stand in Hall 2, Stand G30, where John McKinley (CEO) and Amber Jacobs (PR & Marketing Manager) will […]
Imspex & Biophys Partner to Drive SMART Diagnostics at New South Wales Lab
We are pleased to announce a significant collaboration between Imspex Diagnostics Ltd and Biophys Limited, aimed at advancing SMART diagnostics and R&D services. This partnership coincides with the recent opening of Biophys’s Class 2 laboratory at Mamhilad Park Estate in South Wales, which now provides quality-driven microbiological and R&D laboratory services across various industries. By […]
David Wilson Joins Imspex as Non-Executive Director
Imspex Diagnostics is pleased to announce the appointment of David Wilson to our board of directors as a Non-Executive Director. David brings over 30 years of international experience in the in-vitro diagnostic medical devices industry, providing deep expertise in mergers and acquisitions, business development, and global sales. His vast experience includes leadership roles at Genzyme […]